Fulgent Genetics (NASDAQ: FLGT) holder plans tax-driven share sale

Rhea-AI Filing Summary

Fulgent Genetics, Inc. (FLGT) received a notice under Rule 144 that Jian Xie plans to sell 1,193 shares of common stock through Morgan Stanley Smith Barney LLC. The shares derive from 25,350 shares of restricted stock that vested on February 26, 2024 as equity compensation.

The filing states that this planned sale and prior sales over the past three months were made under "sell to cover" transactions to satisfy tax withholding obligations related to Restricted Stock Units, and are not discretionary trades by the reporting person. Fulgent Genetics had 27,515,293 shares of common stock outstanding as of August 27, 2026.

Key Figures

Shares proposed to be sold: 1,193 shares of common stock Aggregate market value of proposed sale: $23,746.99 Shares outstanding: 27,515,293 shares of common stock +3 more

6 metrics

Shares proposed to be sold 1,193 shares of common stock Rule 144 sale planned through Morgan Stanley Smith Barney LLC

Aggregate market value of proposed sale $23,746.99 Value of 1,193 shares as of August 27, 2026

Shares outstanding 27,515,293 shares of common stock Shares outstanding as of August 27, 2026

Restricted stock vested 25,350 shares Vested on February 26, 2024 as equity compensation

Shares sold on May 27, 2026 1,201 shares for $21,137.57 Reported prior Rule 144 sale

Shares sold on June 2, 2026 2,146 shares for $38,382.27 Reported prior Rule 144 sale

Key Terms

Rule 144, Restricted Stock Units, sell to cover, equity compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"in connection with the vesting of Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"made to satisfy tax withholding obligations through "sell to cover" transactions"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

equity compensation financial

"Equity compensation for services rendered"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

What does Fulgent Genetics (FLGT) disclose in this Rule 144 notice?

The notice states that Jian Xie plans to sell 1,193 FLGT common shares under Rule 144. These shares come from vested restricted stock and the sales are to cover tax withholding obligations related to Restricted Stock Units, not discretionary trading.

How many Fulgent Genetics (FLGT) shares are proposed to be sold under this filing?

The filing lists a proposed sale of 1,193 shares of Fulgent Genetics common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $23,746.99 as of August 27, 2026.

What prior FLGT stock sales by Jian Xie are reported in the last 3 months?

The filing reports sales of 1,201 shares for $21,137.57 on May 27, 2026 and 2,146 shares for $38,382.27 on June 2, 2026, all described as sell to cover transactions for tax withholding.

How many FLGT restricted shares vested that relate to these sales?

The document states that 25,350 shares of Fulgent Genetics common stock were acquired on February 26, 2024 through the vesting of restricted stock as equity compensation for services rendered.

How many Fulgent Genetics (FLGT) shares were outstanding at the time of this notice?

Fulgent Genetics had 27,515,293 shares of common stock outstanding as of August 27, 2026, according to the information provided in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 09:00 AM Accepted by SEC EDGAR 08/27/2026 - 08:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001819718
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FULGENT GENETICS, INC.
SEC File Number	001-37894
Address of Issuer	4399 Santa Anita Ave El Monte CALIFORNIA 91731
Phone	626-350-0537
Name of Person for Whose Account the Securities are To Be Sold	Xie Jian
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th FL New York NY 10004	1193	23746.99	27515293	08/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/26/2024	Resticted stock vest	Fulgent Genetics, Inc.			25350	02/26/2024	Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jian Xie C/O Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte CA 91731	Common Stock	05/27/2026	1201	21137.57
Jian Xie C/O Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte CA 91731	Common Stock	06/02/2026	2146	38382.27

144: Remarks and Signature

Remarks	Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale, along with sales during the past 3 months, were made to satisfy tax withholding obligations through "sell to cover" transactions and do not represent a discretionary trade by the reporting person.
Date of Notice	08/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Paul Kim as Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)